Physician profile
Ivan Tarkin
NPI 1992810493
$242,916.50
in general payments reported to CMS, 2019-2025
6 companies · $170K in 2025
The $170K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $10K · 2022: $8,041 · 2023: $11K · 2024: $43K · 2025: $170K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $130K · Consulting Fee: $76K · Travel and Lodging: $17K · Food and Beverage: $2,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $130,155.90 |
| Consulting Fee | $75,800.00 |
| Travel and Lodging | $16,571.08 |
| Food and Beverage | $2,031.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $241,695.18 | 2019-2025 | Pangea, Pro, T2 Alpha |
| Mid-Atlantic Surgical Systems, LLC | $778.06 | 2023-2024 | |
| Arthrex, INC. | $252.08 | 2023 | |
| Depuy Synthes Sales INC. | $124.99 | 2019 | |
| Bioventus LLC | $46.37 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Abbott Laboratories | $19.82 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Tarkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.